| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
DE:FME
Fresenius Medical Care AG & Co. KGaA
|
Jun 09, 2026 | SELL |
Buy
+27.6% avg upside
21 analysts
|
$37.00
9.05% Downside
|
· |
|
DE:FRE
Fresenius SE & Co. KGaA
|
Jun 03, 2026 | BUY |
Strong Buy
+29.4% avg upside
19 analysts
|
$54.00
36.43% Upside
|
· |
|
GB:CTEC
ConvaTec
|
May 29, 2026 | BUY |
Strong Buy
+41.3% avg upside
16 analysts
|
$375.00
81.13% Upside
|
· |
|
CH:SOON
Sonova Holding AG
|
May 21, 2026 | HOLD |
Sell
+14.3% avg upside
17 analysts
|
$206.00
6.67% Upside
|
· |
|
CH:ALC
Alcon
|
May 21, 2026 | BUY |
Buy
+33.9% avg upside
35 analysts
|
$86.00
62.72% Upside
|
· |
|
FR:BIM
bioMerieux
|
May 21, 2026 | BUY |
Buy
+53.7% avg upside
12 analysts
|
$138.00
99.95% Upside
|
· |
|
GEHC
GE Healthcare Technologies Inc
|
May 21, 2026 | HOLD |
Strong Buy
+36.0% avg upside
20 analysts
|
$69.00
11.93% Upside
|
-4.3% |
|
OBCKF
Ottobock SE & Co. KGaA
|
May 21, 2026 | BUY |
Strong Buy
4 analysts
|
$85.94
|
· |
|
AMBFF
Ambu
|
May 21, 2026 | BUY |
Hold
+12.3% avg upside
2 analysts
|
$14.92
51.39% Upside
|
· |
|
GB:0QBO
Coloplast A/S
|
May 21, 2026 | BUY |
Buy
+87.4% avg upside
16 analysts
|
$530.00
41.87% Upside
|
· |
|
SE:EKTA.B
Elekta AB
|
May 21, 2026 | SELL |
Sell
+23.4% avg upside
12 analysts
|
$39.00
19.70% Downside
|
· |
|
DE:AFX
Carl Zeiss Meditec
|
May 12, 2026 | HOLD |
Hold
+91.0% avg upside
13 analysts
|
$25.00
0.26% Upside
|
· |
|
DE:SHL
Siemens Healthineers AG
|
May 07, 2026 | HOLD |
Strong Buy
+51.7% avg upside
22 analysts
|
$51.00
48.90% Upside
|
· |
|
NL:PHIA
Koninklijke Philips N.V.
|
May 06, 2026 | BUY |
Buy
+31.4% avg upside
20 analysts
|
$32.50
38.34% Upside
|
· |
|
CH:STMN
Straumann Holding AG
|
Apr 30, 2026 | HOLD |
Buy
+19.9% avg upside
13 analysts
|
$71.32
31.77% Downside
|
· |
|
CH:MOVE
Medacta Group SA
|
Apr 23, 2026 | HOLD |
Buy
+10.2% avg upside
4 analysts
|
$151.00
12.79% Upside
|
· |
|
WILLF
Demant
|
Apr 15, 2026 | BUY |
Buy
+10.7% avg upside
19 analysts
|
$37.29
5.11% Upside
|
+25.5% |
|
GB:SN
Smith & Nephew
|
Mar 17, 2026 | HOLD |
Strong Buy
+1305.8% avg upside
15 analysts
|
$1300.00
15.50% Upside
|
· |
|
GB:0QIU
Novo Nordisk
|
Jan 25, 2022 | SELL |
Hold
+43.2% avg upside
28 analysts
|
— | · |
|
CH:NOVN
Novartis AG
|
Jan 25, 2022 | HOLD |
Buy
-9.8% avg upside
30 analysts
|
— | · |
|
GB:AZN
AstraZeneca
|
May 29, 2020 | BUY |
Strong Buy
+12.2% avg upside
26 analysts
|
— | · |
|
GB:GSK
GlaxoSmithKline
|
May 28, 2020 | HOLD |
Hold
-2.9% avg upside
25 analysts
|
— | · |
|
DE:BAYN
Bayer
|
Jan 22, 2020 | BUY |
Strong Buy
+33.6% avg upside
28 analysts
|
$90.00
137.79% Upside
|
· |
|
CH:ROP
Roche Holding AG
|
Jun 20, 2019 | HOLD |
Buy
+3.3% avg upside
23 analysts
|
$275.00
14.10% Downside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.